Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Annatto-derived Geranylgeraniol (GG) on Statin-associated Myopathy

NCT05312424 is registered in ClinicalTrials.gov with Texas Tech University Health Sciences Center as lead sponsor.

NCT NCT05312424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05312424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Annatto-derived Geranylgeraniol (GG) on Statin-associated Myopathy
Lead sponsor
Texas Tech University Health Sciences Center
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 15, 2022
Completion date
December 31, 2027
Enrollment
95 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopathy; primary